Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients

Author： Kwan Jonathan T. C.   Pratt Raymond D.    

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.2, 2007-02, pp. : 307-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epoetin delta is effective for the management of anaemia associated with chronic kidney disease

By Spinowitz Bruce S.   Pratt Raymond D.    

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2507-2513

Informa Healthcare

Access to resources Recommend Favorite

Cutaneuos findings in patients with predialysis chronic kidney disease

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 30, Iss. 9, 2016-09 ,pp. : 1609-1613

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparing the efficacy of continuous erythropoietin receptor activator and darbepoetin Alfa treatments in Japanese patients with chronic kidney disease during the predialysis period: A propensity‐matched analysis

By  

NEPHROLOGY, Vol. 20, Iss. S4, 2015-12 ,pp. : 22-28

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of renal anaemia with erythropoiesis‐stimulating agents in predialysis chronic kidney disease patients: Haemoglobin profile during the 6 months before initiation of dialysis

By  

NEPHROLOGY, Vol. 20, Iss. S4, 2015-12 ,pp. : 29-32

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence, Patterns of Treatment, and Control of Hypertension in Predialysis Patients with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 120, Iss. 3, 2012-06 ,pp. : c147-c155

Karger

Access to resources Recommend Favorite